 BEIJING--BUSINESS WIRE--Genetron Holdings Limited Genetron Health or the Company, NASDAQ: GTH sponsored a ScienceAAAS Webinar, Early cancer screening today and tomorrow: Exploring liquid biopsy profiling for diagnosis and treatment, which launched today. During the panel discussion, Genetron Healths Chief Technology Officer, Dr. Yuchen Jiao, gave a speech entitled Profiling cfDNA-based Biomarkers for the Early Detection of Cancer. In his presentation, Dr. Jiao highlighted the impo 